Entelo Bio
Medical AI · Precision Medicine
Overview
Entelo Bio is building the evidence chain in Human Resilience. We do this by decoding biology, developing medicines and derisking translation.
Funding and backers
Team
11-50
employees, estimated range
Backers
2
Ananda Impact Ventures, The Creator Fund
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Hepta, Rex Animal Health
backs Neuron23
Similar startupsby what they do, their industry and backers
Neuron23 is developing a precision medicine approach designed to improve the lives of people with Parkinson’s disease.
Bringing Precision Medicine to the Animal Health.
Geneoscopy is passionate about the work we do, committed to excellence and believes that improvements in personalized medicine can impact…
Founded in 2021 by four Seoul National University medical researchers, Portrai fuses spatial biology and AI to make drug development…
Hepta is decoding tissue-level biology from blood, starting with MASH. LiquidTransformer, our liquid biopsy-native AI platform, reads…
A Boston-based biotech startup developing medicines for patients with autoinflammatory disease.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Ananda Impact VenturesVia a fund
The Creator FundVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely